Fish dorsomedial telencephalon has been considered a pallial region homologous to mammals amygdala, being considered a possible substrate for nociception modulation in this animal group. The present study aimed to evaluate the participation of the cannabinoid system of Dm telencephalon on nociception modulation in the fish Leporinus macrocephalus. We demonstrated that cannabidiol microinjection in Dm telecephalon inhibits the behavioral nociceptive response to the subcutaneous injection of 3% formaldehyde, and this antinociception is blocked by previous treatment with AM251 microinjection. Furthermore, AM251 microinjection in Dm prior to restraint stress also blockades the stress-induced antinociception. These results reinforce the hypothesis that this pallial telencephalic structure has a pivotal role in nociception modulation in fish.
Introduction
A series of recent studies have demonstrated the effect of noxious stimuli on fish behavior and physiology [1] [2] [3] [4] [5] [6] . However, knowledge about antinociception and its neurochemical substrates are still incipient. Regarding brain anatomy, fish do not possess a neocortical structure, and the pallium is primitive compared to that of mammals, which has led many scientists to claim the occurrence of complex nociceptive responses but to reject the occurrence of pain perception [7] [8] [9] [10] . Despite the absence of neocortical structures, the fish telencephalon possesses structures that are considered homologous to mammal's amygdale and hippocampus; as such, these structures are potentially able to modulate defensive responses. Therefore, the understanding of fish telencephalic mechanisms and neurochemical systems involved in nociception modulation is indispensable to evaluate the degree of complexity of the response to a noxious stimulus and the antinociceptive mechanisms this group.
The teleost fish dorsomedial telencephalon (Dm) is a pallial brain structure that may be a neural substrate for nociception processing, as it has been implicated in memory and a form of learning referred to by Portavela [11, 12] as "emotional learning", and is considered by some authors to be functionally homologous to the mammalian amygdala [11, 12] . This homology is also supported by the pattern of connectivity and the presence of GABA A -benzodiazepine receptors [13] [14] [15] [16] [17] . Recent research has reinforced this view and related this pallial region to nociception processing, demonstrating that the Dm is also involved in nociception modulation, by inhibiting stress-induced antinociception by microinjection with midazolam, a GABA A benzodiazepine receptor agonist [18] , similar to what is observed after midazolam and diazepam microinjection in the amygdala of mammals [19, 20] .
Despite the involvement of the Dm GABAergic system in the modulation of fish nociception, there is no evidence of other neurochemical systems involved in this function. Systemic injections of drugs that interfere with cannabinoid and opioid systems modulate fish nociception [5, 6] , the CB1 receptor gene is highly expressed in the fish dorsal telencephalon [21] , and its expression is increased after noxious stimulation in the fish telencephalon [22] , suggesting involvement of the telencephalic cannabinoid system in nociception processing.
Thus, the objective of the present study was to evaluate the involvement of the cannabinoid system of the Dm in the induction of antinociception and the modulation of stress-induced antinociception in the fish Leporinus macrocephalus, using cannabidiol, a cannabinoid substance, and AM251, a cannabinoid receptor type I (CB1) antagonist.
Materials and methods

Husbandry and set-up
The present study used a total of 112 juvenile piauçu fish (Leporinus macrocephalus) (23.45 ± 3.10 g weight), two months old, obtained from a fish farm and maintained in stock tanks (100 × 100 × 60 cm; n = 50) until the experimental period began. Fish were subjected to unilateral guide cannula implantation in the skull overlying the Dm telencephalon [18] , and transferred to individual glass aquaria (40 × 22 × 20 cm,~18 l) in a closed system with aerated water (pH: 7.35 ± 0.04; temperature: 26 ± 1°C; unionized ammonia (NH 3 ): lower than 0.04 mg·l − 1 ), five days prior to the experiment. The sidewalls of the aquaria were covered with opaque white paper and the water was not replaced to avoid disturbance. The light/dark cycle was 12:12 h (light starting at 07:00 and ending at 19:00) and all of the experiments were conducted at the same time of day (between 8:00 and 10:00) to avoid circadian interference. The animals were fed daily with pelleted food corresponding to 3% of the biomass of the fish.
Surgical procedures
The guide cannula implant was performed using previously described methodology [18] . To implant the guide cannula, the fish were anesthetized through immersion in MS-222 (0.20 g l ) until the termination of skeletomotor and opercular movements and enveloped in humidified cotton to protect the skin epithelium; during surgery, the fish remained under hydraulic ventilation through the gills with aerated water containing anesthetic maintenance solution (MS-222: 0.10 g l − 1 ).
The animal was attached to a confinement acrylic box coupled with a prior micromanipulator, and a guide cannula with 7 mm in length and 0.5 mm in outer diameter, prepared from a hypodermic needle, was implanted unilaterally (left side) on the skull overlying the Dm telencephalon, following the stereotaxic coordinates of 1.5 mm caudal to frontal zero plane (junction of the olfactory bulb with the telencephalon midline) and 0.35 mm lateral to the midline. The guide cannula was fixed to the skull using a mixture of auto-polymerizing acrylic (Symplex, DFL, Ind. Com) and instant glue (Super Bonder, Loctite).
The guide cannula (7 mm) was inserted in this position, and the injection point, inside the Dm telencephalon, was located at + 0.1 mm, achieved using an injection needle (7.1 mm). After the surgery, all animals recovered from surgery for 5 days.
Nociceptive test
The nociceptive test was performed as previously described [5, 6, 18] . Subcutaneous injections of approximately 20 μl of 3% formaldehyde (Formaldehyde P.A. -A.C.S. 37%, pKa = 13.3, stabilized with 10% methanol, Merck, Darmstadt, FRG, www.merck.com) in the region of the adipose fin (located medially between the dorsal and the caudal fin) were used as the noxious stimulus. For subcutaneous injection, fish were removed from the water using nylon nets, wrapped in wet cloth and immediately returned to the water.
Restraint stress
The restraint procedure was based on a previously described methodology [5, 6, 18] , using a metal screen in the aquarium (30 × 20 × 3 cm) to prevent fish movements for 3 or 5 min without restricting the opercular movements. Restraint is a physiologically stressful condition for fish and inhibits nociceptive responses promoted by the formaldehyde nociceptive test [5, 6, 18] .
Behavioral analysis
The behavioral analysis evaluated the locomotor activity (distance travelled, 5 min of baseline and 5 min post-stimulus) of fish during the experiment recorded using a camera (Sony CCD-TRV 318, California, USA, www.sony.com) coupled to a computer with image capturing software placed in front of the longest face of the aquarium. The distance travelled was analyzed using EthoVision XT 7.1 software (Noldus Information Technology, Wageningen, NL), and the data are expressed as the differences (Δ) in the values before (baseline) and after (poststimulus) methodological interventions (Δ = post-stimulus − baseline) (baseline and post-stimulus data are presented as supplementary material). The experimenter was blinded to the treatment during the analysis, and a reliability test was performed for the video analysis. 
Tocris Bioscience, Bristol, UK, diluted in a solution of saline + 10% DMSO at a concentration of 50 ng/0.1 μl) microinjection. The cannabidiol and AM251 doses were based on studies in mammals [23] . Fish locomotor activity was recorded for 5 min (baseline) before microinjection of the vehicle or AM251. After 5 min, a group of fish received a cannabidiol microinjection (n = 28; vehicle: n = 14 and AM251: n = 14) and the other group received a vehicle microinjection (n = 28; vehicle: n = 14 and AM251: n = 14, per group). After 5 min, the fish was submitted to the formaldehyde nociceptive test (subcutaneous injection of saline (n = 7 per treatment) or 3% formaldehyde (n = 7 per treatment) and locomotor activity was recorded for 5 min (post-stimulus) (Fig. 1 ).
Experiment 2. Influence of AM251 microinjection in the Dm telencephalon on the antinociception induced by restraint stress
In this experiment, the effects of AM251 microinjection in the Dm telencephalon on behavioral responses to restraint stress-induced antinociception were assessed. Fish locomotor activity was recorded for 5 min (baseline) prior to the microinjection of 0.1 μl of vehicle or AM251 (50 ng) in the Dm through the previously implanted guide cannula. After 5 min, a group of fish was not subjected to restraint (n = 28; vehicle: n = 14 and midazolam: n = 14), while the other two groups were subjected to 3 or 5 min of restraint (n = 28; vehicle: n = 14 and midazolam: n = 14, per group) to induce antinociception [5, 6, 18] . After 5 min, the fish were subjected to the formaldehyde nociceptive test (subcutaneous injection of saline or 3% formaldehyde; Fig. 1 . Schematic drawing of the experimental sequence. B -baseline recording; Vvehicle microinjection; A -AM251 microinjection; C -cannabidiol microinjection; Ssubcutaneous saline injection; F -subcutaneous formaldehyde injection; PS -post-stimulus recording. n = 7 per treatment) and locomotor activity was recorded for 5 min (post-stimulus) (Fig. 2) .
Histological verification
After the experiments, the site of injection was verified by histological preparation of the fish brain, as previously described [18] . First, the fish was anesthetized by immersion in MS-222 (0.20 g l − 1 ), subjected to an electrolytic lesion to identify the microinjection site using a metallic microelectrode (continuous current of 1 mA for 5 s, Frederick Haer & Co., Bowdoinham, ME, USA). Subsequently, the head was removed, fixed in formaldehyde for 5 days and submitted to routine histological procedures, where the material was embedded in paraffin and the sections were stained with cresyl violet dye. The stained preparations were observed under a light microscope to determine the location of the microinjections. Only fish with a positive microinjection site in the Dm were considered for data analysis. Coronal sections with the localization of the microinjections are presented in Fig. 3 .
Statistical analysis
The results are expressed as the means ± SEM. Normality (Kolmogorov-Smirnov test) and variance homogeneity (Levene's test) was evaluated prior to the statistical analysis. In Experiment 1, the locomotor activity (total distance travelled) presented a normal distribution (P > 0.05) and homogeneity of variance (P > 0.05). A three-way ANOVA was used to compare the three independent variables: first microinjection (vehicle or AM251), second microinjection (vehicle or cannabidiol) and formaldehyde test (subcutaneous injection with saline or formaldehyde), followed by Tukey's post-hoc test when significant main effects were identified. A value of P ≤ 0.05 was considered statistically significant for all statistical comparisons.
In Experiment 2, the locomotor activity (total distance travelled) data presented a normal distribution (P > 0.05) and homogeneity of variance (P > 0.05). A three-way ANOVA was used to compare the three independent variables: microinjection pre-treatment (vehicle or AM251), restraint stress duration (0, 3 or 5 min) and formaldehyde test (subcutaneous injection with saline or formaldehyde). When main effects were identified, Tukey's post-hoc test was performed. A value of P ≤ 0.05 was considered statistically significant for all statistical comparisons. All statistical comparisons were performed using Sigma Stat 32.
Ethics statement
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Results
Experiment 1. Effect of cannabidiol microinjection in Dm telencephalon on the nociceptive response to 3% formaldehyde
There was a significant interaction between the three factors (microinjection of AM251 or vehicle, microinjection of cannabidiol or vehicle and subcutaneous injection of formaldehyde or vehicle) (ANOVA: F 48,1 : 9.832; P = 0.003). Fish receiving two vehicle microinjections presented an increase in locomotor activity after receiving a subcutaneous injection of formaldehyde in the region of the adipose fin when compared with fish receiving a subcutaneous injection of saline (Tukey HSD: P < 0.001), while fish receiving the first vehicle microinjection followed by a cannabidiol microinjection did not present an increase in locomotor activity after subcutaneous formaldehyde injection. AM251 microinjection in fish that received vehicle as the second microinjection did not promote alterations in locomotor activity after the formaldehyde test. However, fish pre-treated with AM251 prior to the cannabidiol microinjection responded behaviorally to the formaldehyde subcutaneous injection, presenting a significant increase in locomotor activity when compared with the fish pre-treated with a vehicle microinjection (Tukey HSD: P < 0.001) (Fig. 4) .
Experiment 2. Influence of AM251 microinjection in the Dm telencephalon on antinociception induced by restraint stress
There was a significant interaction between the three factors (microinjection of AM251 or vehicle, restraint duration and subcutaneous injection of formaldehyde or vehicle) (ANOVA: F 72,2 : 5.043; P = 0.009). Fish receiving a vehicle microinjection and not submitted to restraint presented an increase in locomotor activity after receiving subcutaneous injection of formaldehyde in the region of the adipose fin when compared with fish receiving saline (Tukey HSD: P < 0.001), while fish receiving a vehicle microinjection and submitted to 3 or 5 min of restraint did not present an increase in locomotor activity after formaldehyde subcutaneous injection. AM251 microinjection in fish not submitted to restraint did not promote alterations in locomotor activity after the formaldehyde test. However, fish pre-treated with AM251 prior the 3 and 5 min of restraint stress responded behaviorally to the subcutaneous formaldehyde injection, presenting a significant increase in locomotor activity when compared with fish pre-treated with a vehicle microinjection (Tukey HSD: P < 0.001). In fish submitted to 5 min of restraint, a similar result was observed (Fig. 5 ).
Discussion
Our results demonstrate that the activation of the cannabinoid system in the Dm telencephalon, via CB1 receptors, inhibits the behavioral responses to noxious stimulation (i.e. increase in locomotor activity) in the fish L. macrocephalus.
Formaldehyde test, a nociceptive test extensively used for mammals and adapted for the fish L. macrocephalus [24] , was used in the present study. The application of 3% formaldehyde subcutaneous injection promotes a significant increase in locomotor activity, expressed by the increase in distance travelled and the swimming speed of the fish, associated to an erratic patter of swim [5, 6, 18, 24] . These behavioral responses to the noxious stimulation are used as indicators of nociception for this species, and the inhibition of these behavioral responses by stressful stimuli and drugs administration has been interpreted as antinociception [5, 6, 18, 24] .
Previous studies from our laboratory demonstrated that 3 and 5 min of restraint inhibit the nociceptive behavioral responses to formaldehyde test, suggesting that this kind of stressful stimulus may induce the release of analgesic substances, such as opioid and canabinoid, in L. macrocephalus, modulating the nociceptive behavioral output [5, 6, 18] . Although there have not been studies evaluating the brain structures and descending pathways involved in this modulation in fish, evidence suggests that the Dm telencephalon may play an important role, since it was demonstrated that the microinjection of midazolam, GABA A benzodiazepine receptor agonist, blocks the inhibition of behavioral responses to noxious stimulation induced by restraint stress [18] . In the present study, the microinjection of AM251, a cannabinoid CB1 receptor antagonist, presented the same effect, blocking the inhibition of nociceptive behavioral output induced by restraint. Futhermore, cannabidiol microinjection in Dm also inhibited the behavioral response to noxious stimulation, providing new evidence regarding the importance of the Dm telencephalon in this phenomenon, and reinforcing the hypothesis that the Dm telencephalon can be part of a descendent pathway that modulates fish nociceptive behavioral output. Although the histological verification confirmed the site of injection, we cannot completely discard the possibility of the drug spreading to other subjacent brain areas, from Dm telencephalon. However, drug volume used for microinjection in this study was small (0.1 μl) to minimize the spreading risks.
The fish Dm telencephalon is a pallial region that has been considered homologous to the tetrapod amygdala [25] . This homology, first proposed by topological studies [26] , has been confirmed by behavioral [27] , genetic [28] and connection studies [14, 25] . The role of the Dm telencephalon on modulation of nociceptive behavior observed in our study also suggests similarities between this region and the mammalian amygdala. In mammals, the amygdaloid complex plays a pivotal role mediating stress-induced analgesia [29] . Amygdala electric stimulation promotes analgesia in rodents [30, 31] . Furthermore, the analgesia promoted by electric stimulation of the amygdaloid central nucleus in rats involves an opioid descending pathway [32] that seems to project from the amygdala to the periaqueductal gray (PAG), since naloxone microinjection in the PAG inhibits analgesia induced by amygdaloid central nucleus stimulation [33] . Lesions in this same nucleus also decrease the stress-induced analgesia promoted by 20 min of regular and intermittent electroshock [34, 35] and morphine-induced analgesia during the formaldehyde nociceptive test [36] , suggesting that the integrity of the amygdaloid complex may be essential for inducing analgesia. In mammals, evidence also suggests that the amygdaloid complex, nucleus accumbens and PAG form a network of reciprocal connections involved in analgesia induction, since morphine microinjections in one of these regions promotes encephalin and β-endorphin release in the other regions [37] . In fish, more studies are necessary to evaluate the existence of a descending pathway, probably starting from the Dm telencephalon, and the involvement of other brain regions modulating the behavioral responses to noxious stimulation.
The cannabinoid system in the Dm telencephalon seems to play an important role generating inhibition of behavioral responses to noxious stimulation in fish. Although cannabinoid receptors were described in mammals as recently as the 1990s [38, 39] , further studies have shown that these receptors are widely distributed in the fish brain, and are found in the telencephalon, preoptic area, hypothalamus, pituitary, brain stem and cerebellum [21, [40] [41] [42] . The CB1 receptor coding gene is highly expressed in the fish dorsal telencephalon, the region evaluated in the present study, suggesting that these receptors may be involved in cognitive processes [21] . Moreover, upregulation of this gene has been described after noxious stimulation in rainbow trout [22] , supporting the hypothesis that the cannabinoid system is involved in nociceptive processing in fish. Our results suggest that modulation of the behavioral responses to noxious stimulation by the Dm telencephalon cannabinoid system is similar to that observed in mammals, since the application of cannabidiol, a cannabinoid agonist, in the Dm telencephalon promoted inhibition of behavioral responses to noxious stimulation, that was blocked by AM251, suggesting the participation of CB1 receptors in this modulation, as observed in the mammalian amygdala after cannabinoid agonist application [43, 44] . In rodent models, the analgesia promoted by treatment with WIN 55,212-2 (a cannabinoid agonist) can also be blocked by the application of muscimol, a GABA A receptor agonist, in the amygdaloid central nucleus [45] . The involvement of the GABAergic system in modulation of nociceptive behavior in fish has been previously demonstrated [18] by the blockade of stress-induced antinociception by midazolam microinjection in the Dm telencephalon. Current evidence supports the hypothesis that the inhibition of nociceptive behavioral responses in fish seems to involve the opioid, cannabinoid and GABAergic systems, and the Dm telencephalon is an important neural substrate for this modulation; however, the interactions between these systems and the participation of other neural substrates still need evaluation.
In conclusion, we have shown that inhibition of the behavioral responses to noxious stimulation in fish involves an endogenous cannabinoid system, via CB1 receptors in the Dm telencephalon, in addition to the previously demonstrated GABA A benzodiazepine receptors [18] , reinforcing the hypothesis that this pallial telencephalic structure may be involved in modulation of nociceptive behavioral output in fish.
